Today was the day for my quarterly (or more precisely, 12-week) blood (PSA) test. I am checking the effectiveness of the ...
She was an 80-year-old woman.There was a breast cancer about 3 cm in size in her right breast, and a portion of it had ...
A recent analysis of the NRG-RTOG 0534 "SPPORT" clinical trial evaluated the Luminal B (LumB) molecular subtype using the ...
5hon MSN
Exercise program supports better attention and slows biological aging in breast cancer survivors
One in three breast cancer survivors will experience cognitive problems, which can include difficulties with attention, ...
(Nasdaq: VCYT), a leading cancer diagnostics company, announced that new findings from a retrospective ancillary analysis of the randomized phase III NRG/RTOG 0815 trial will be presented at the 2026 ...
On Tuesday, Veracyte ( VCYT) announced new findings from a retrospective analysis of the Phase 3 NRG/RTOG 0815 trial showing that its Decipher Prostate Genomic Classifier can identify ...
Texas A&M researchers are leading an NIH collaboration searching natural compounds for new ways to treat advanced prostate ...
With prostate cancer survival continuing to improve, the long-term cardiovascular consequences of androgen deprivation ...
Survivorship introduces financial toxicity beyond direct medical costs, exemplified by barriers to obtaining affordable life insurance in young adults with recurrence risk. Long-term care planning ...
A recent analysis of the NRG-RTOG 0534 "SPPORT" clinical trial evaluated the Luminal B (LumB) molecular subtype using the ...
Because most women with HR-positive breast cancer are advised to avoid hormone therapy, a nonhormonal option matters. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results